Jared Holt on why innovation may not be such a good thing for biotech
A health care strategist with Oppenheimer discusses the downturn in biotech stocks and what it means for the industry.
Posted on June 6, 2022 by Design in Design Innovation | 0 Comments
A health care strategist with Oppenheimer discusses the downturn in biotech stocks and what it means for the industry.
Copyright © 2024 | DLIT.CO